Form 4: Incyte Director Susanne Schaffert Reports Significant Equity Transactions, Including RSU and Option Grants

Incyte Corporation Director Susanne Schaffert reported the acquisition of 2,518 restricted stock units and 9,216 non-qualified stock options, alongside the disposition of 849 shares for tax withholding, as detailed in a recent SEC Form 4 filing.

Summary

• Susanne Schaffert, a Director of Incyte Corporation (INCY), reported transactions on June 10, 2025.
• She disposed of 849 shares of common stock at a price of $70.07 per share to satisfy tax withholding obligations related to previously reported restricted stock units.
• She acquired 2,518 restricted stock units (RSUs) with a grant price of $0, which are scheduled to vest in full on the first anniversary of the grant date (June 10, 2025), or earlier upon the next annual meeting or a change of control.
• She also acquired 9,216 non-qualified stock options with an exercise price of $70.07, which vest under similar conditions to the RSUs and have an expiration date of June 9, 2035.
• Following these transactions, her direct beneficial ownership of common stock is 7,389 shares, which includes the unvested RSUs.
• Her direct beneficial ownership of derivative securities (options) is 9,216.

Sentiment

Score: 7

Explanation: The filing indicates routine equity compensation for a director, aligning their interests with shareholders through RSU and option grants. The disposition for tax purposes is a standard procedure. Overall, it reflects normal corporate governance and compensation practices without indicating any significant positive or negative operational news.

Positives

• The grant of 2,518 restricted stock units (RSUs) and 9,216 non-qualified stock options indicates ongoing compensation and incentive alignment for Director Susanne Schaffert, linking her interests to the company's performance.
• The defined vesting schedule for both RSUs and options (one year or next annual meeting/change of control) provides a clear timeline for equity realization, encouraging long-term commitment.

Negatives

• The disposition of 849 shares of common stock to cover tax withholding obligations reduces direct share ownership, although this is a common and expected practice for equity awards.

Future Outlook

The document details the vesting schedules for the granted restricted stock units and stock options, indicating that these equity awards will vest in full on the first anniversary of the grant date (June 10, 2025), or earlier upon the date of the next regular annual meeting of the Company's stockholders or a change of control.

Industry Context

This Form 4 filing is a routine disclosure of an individual director's equity transactions and compensation, which is standard practice across publicly traded companies. It does not provide broader industry trends or competitive insights.

Corporate Governance

Related Party Transactions

• The acquisition of restricted stock units and non-qualified stock options by Director Susanne Schaffert from Incyte Corporation represents a routine related-party transaction as part of her compensation package.

Stakeholder Impact

• Shareholders: The grant of equity awards to a director aligns their financial interests with those of the shareholders, as the value of these awards is directly tied to the company's stock performance. The tax-related disposition is a routine event and does not typically impact shareholder value.

Next Steps

• Vesting of 2,518 Restricted Stock Units on June 10, 2026 (first anniversary) or earlier, based on the specified conditions.
• Vesting of 9,216 Non-Qualified Stock Options on June 10, 2026 (first anniversary) or earlier, based on the specified conditions.
• Potential exercise of Non-Qualified Stock Options before their expiration date of June 9, 2035.

Key Dates

Recommendation

Keywords

Incyte Corporation, INCY, Susanne Schaffert, SEC Form 4, Insider Trading, Restricted Stock Units, Stock Options, Equity Compensation, Director Compensation, Beneficial Ownership, Tax Withholding, Corporate Governance